Clinical Trials Browser

OTHER × Prostatic Neoplasms × antineoplaston AS 2-1 × Clear all

NCT00003516 2018-02-05

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00003534 2018-01-31

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00003533 2017-12-12

Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms